CLINICAL_TRIALS
trial_result
· 2008-10-02
Clinical Trial Update: Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus [Phase 2]
Summary
A Phase II clinical trial evaluating high-dose cyclophosphamide in patients with refractory pemphigus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Pemphigus | Phase 2 | Status: COMPLETED